Posted in | News | Rubber and Elastomer

Goodyear Propose Closing New Zealand Tire Plant

The Goodyear Tire & Rubber Company today announced a proposal to close a tire plant in New Zealand as part of its strategy to reduce high-cost manufacturing capacity globally.

"A key component of our strategy is the elimination of high-cost tire manufacturing capacity," said Goodyear Chairman and Chief Executive Officer Robert J. Keegan. "Our objective is to take actions over the next three years that will result in annual savings of between $100 million and $150 million."

The company's South Pacific Tyres (SPT) business has initiated consultation with associates and union representatives regarding the proposal to close the plant in Upper Hutt, New Zealand. The plant, which has about 400 associates, produces about two million radial passenger car tires per year.

Goodyear and SPT remain committed to the consumer and commercial tire markets in New Zealand and would supply customers with product produced in other countries in the Asia Pacific region, according to SPT Chief Executive Officer Joseph Copeland. Manufacturing in New Zealand has experienced greater pressure than in many other markets due to high costs, competition from low- cost imports and the lack of domestic auto production.

The proposed closure is expected to be completed within six to eight months and create annual cost savings of approximately $15 million in Goodyear's Asia Pacific region. It would result in restructuring charges of approximately $35 million ($35 million after tax), of which approximately $20 million is expected to be cash charges.

Formed in 1987 as a joint venture, SPT has been wholly owned by Goodyear since January 2006. The leading tire maker and marketer in Australia and New Zealand, it has 4,000 associates and annual sales of more than $700 million. Its results have been consolidated with those of Goodyear's Asia Pacific region since January 2004.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.